Judging by its 2023 reported investment activity, it seems Andreessen Horowitz is a lot less bullish than in recent past years.
Health, Wellness & Biotech
San Francisco- and London-based Aiolos Bio, a newly launched startup with an asthma drug in clinical trials, announced that it raised $245 million in...
There is only one way to describe this week — incredibly slow. For the first time in a while, there wasn’t a round that hit nine figures. After a...
At least 20 global companies made debuts on the Nasdaq and NYSE in 2021 at initial valuations above $10 billion. Since then, some buzzy names have...
Once again no single investor really dominated the list in September with only one making more than a dozen deals, and just two reaching double...
For weeks it seemed like investors couldn’t take part in enough nine-figure rounds. Well, that all stopped this week, as only one round topped $100...
The big rounds ran the gamut, from parking (yes, parking!) to energy to good ol' AI.
AI, space and biotech were the big winners, raising more than $2 billion in the top five rounds. The last several weeks have definitely seen the big...
There were two raises of $1 billion or more this month, and it took at least $210 million to make this list. Of course, AI played a role.
So far in 2023, Seattle-based startups have pulled in $1.1 billion in seed through growth-stage financing, per Crunchbase data. That’s a decline of...
Vacations are over, everyone’s back in school, football’s here and we are in the full swing of fall. That means some pretty fascinating rounds may...
67.1K Followers